Guardant Health Inc

For the period ended Dec 31, 2024. Filed Feb 20, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 20, 2025

GH$155.35-2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders' Equity (Deficit)

(in thousands, except share data)

Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balance as of January 1, 2022	101,767,446	$1	$1,657,593	$(4,764)	$(1,007,825)	$645,005
Issuance of common stock upon exercise of stock options	228,311	—	2,625	—	—	2,625
Vesting of restricted stock units	315,673	—	—	—	—	—
Vesting of common stock exercised early	—	—	8	—	—	8
Issuance of common stock under employee stock purchase plan	307,953	—	9,316	—	—	9,316
Employee taxes paid related to settlement of restricted stock units	—	—	(7,878)	—	—	(7,878)
Stock-based compensation	—	—	94,685	—	—	94,685
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	—	—	(14,235)	—	—	(14,235)
Other comprehensive loss	—	—	—	(14,758)	—	(14,758)
Net loss	—	—	—	—	(654,588)	(654,588)
Balance as of December 31, 2022	102,619,383	1	1,742,114	(19,522)	(1,662,413)	60,180
Issuance of common stock upon follow-on offering, net of offering costs of $21,131	14,375,000	—	381,369	—	—	381,369
Issuance of common stock upon registered direct offering	3,387,446	—	90,616	—	—	90,616
Issuance of common stock upon exercise of stock options	51,124	—	405	—	—	405
Vesting of restricted stock units	732,038	—	—	—	—	—
Issuance of common stock under employee stock purchase plan	464,870	—	10,154	—	—	10,154
Employee taxes paid related to settlement of restricted stock units	—	—	(11,197)	—	—	(11,197)
Stock-based compensation	—	—	90,759	—	—	90,759
Other comprehensive income	—	—	—	15,847	—	15,847
Net loss	—	—	—	—	(479,449)	(479,449)
Balance as of December 31, 2023	121,629,861	1	2,304,220	(3,675)	(2,141,862)	158,684
Issuance of common stock upon exercise of stock options	609,495	—	3,119	—	—	3,119
Vesting of restricted stock units	1,176,892	—	—	—	—	—
Issuance of common stock under employee stock purchase plan	577,758	—	11,719	—	—	11,719
Employee taxes paid related to settlement of restricted stock units	—	—	(15,681)	—	—	(15,681)
Stock-based compensation	—	—	140,411	—	—	140,411
Other comprehensive loss	—	—	—	(1,526)	—	(1,526)
Net loss	—	—	—	—	(436,373)	(436,373)
Balance as of December 31, 2024	123,994,006	$1	$2,443,788	$(5,201)	$(2,578,235)	$(139,647)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.